Literature DB >> 4414661

Methotrexate treatment for advanced bladder cancer.

R R Hall, H J Bloom, J E Freeman, A Nawrocki, D M Wallace.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4414661     DOI: 10.1111/j.1464-410x.1974.tb10181.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


× No keyword cloud information.
  7 in total

1.  Chemotherapy in bladder cancer.

Authors: 
Journal:  Br Med J       Date:  1977-12-17

2.  Treatment of infiltrating bladder cancer.

Authors:  H J Bloom
Journal:  J R Soc Med       Date:  1979-03       Impact factor: 5.344

Review 3.  Chemotherapy of advanced transitional cell carcinoma of the uroepithelium.

Authors:  F M Torti; W G Harker
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

4.  Phase II study of VP 16-213 (etoposide) in metastatic transitional cell urothelial cancer.

Authors:  B A Ponder; R T Oliver
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

5.  The chemotherapy of advanced bladder cancer.

Authors:  D W Newling; G Stoter; R Sylvester; M de Pauw
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

Review 6.  Chemotherapy in the management of invasive bladder cancer. A review.

Authors:  H Bush; N Thatcher; R Barnard
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

Review 7.  Overview of Dual-Acting Drug Methotrexate in Different Neurological Diseases, Autoimmune Pathologies and Cancers.

Authors:  Przemysław Koźmiński; Paweł Krzysztof Halik; Raphael Chesori; Ewa Gniazdowska
Journal:  Int J Mol Sci       Date:  2020-05-14       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.